Intravenous Infusions Plc (GHSE:IIL)
Ghana
· Delayed Price · Currency is GHS 0.0400
0.00 (0.00%)
At close: Aug 6, 2025
Intravenous Infusions Revenue
In the year 2024, Intravenous Infusions had annual revenue of 24.94M GHS, down -20.62%. Intravenous Infusions had revenue of 12.33M in the half year ending December 31, 2024, with 18.06% growth.
Revenue
24.94M
Revenue Growth
-20.62%
P/S Ratio
0.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24.94M | -6.48M | -20.62% |
| Dec 31, 2023 | 31.42M | 11.06M | 54.34% |
| Dec 31, 2022 | 20.36M | -2.32M | -10.21% |
| Dec 31, 2021 | 22.67M | 2.00M | 9.69% |
| Dec 31, 2020 | 20.67M | -2.42M | -10.47% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Scancom | 21.18B |
| Standard Chartered Bank Ghana | 1.66B |
| TotalEnergies Marketing Ghana | 7.25B |
| Ecobank Ghana | 4.55B |
| Access Bank (Ghana) | 1.62B |
| GCB Bank | 4.89B |
| Guinness Ghana Breweries | 3.17B |
| Agricultural Development Bank | 126.59M |